ACIP voted to recommend against anyone — adult, child and pregnant person — receiving a seasonal flu vaccine with the mercury-containing compound thimerosal.

(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RSV jab, while South32 warned of an impairment at an ...

Canadian livestock researchers are using metagenomics to identify disease impacting beef cattle through bacteria, pathogens and viruses.

The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age, expanding protection options ahead of the 2025–2026 season.

Indian pediatric experts report that Respiratory Syncytial Virus (RSV) causes a significant number of infant respiratory infections, yet cases are und ...

ENFLONSIA is Merck’s extended half-life monoclonal antibody (mAb) indicated for passive immunization for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in ...

COVID-19 has recently surpassed the flu and respiratory syncytial virus (RSV) in test positivity, emergency room visits, and ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage trials of obeldesivir. | Gilead has blamed the low rate of respiratory ...

Dear: My husband and I are in our 50’s and would like to know what resources you recommend for locating senior discounts, and ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9.

The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and ...